Use of a copolymer dressing on superficial and partial-thickness burns in a paediatric population

M Everett1, S Massand2, W Davis1

  • 1St Christopher's Hospital for Children, Philadelphia, PA USA.

Journal of Wound Care
|July 23, 2015
PubMed

Insights

This pilot study shows that a copolymer dressing effectively treats partial-thickness burns in children, allowing for shorter hospital stays and high patient satisfaction. The synthetic dressing is easy to apply and manage, reducing pain and infection risk.

Area of Science:

  • Burn Care
  • Wound Healing
  • Biomaterials

Background:

  • No single dominant treatment exists for partial-thickness burns.
  • Copolymer dressings offer a novel approach to wound management.

Purpose of the Study:

  • To evaluate the efficacy and outcomes of copolymer dressing (Suprathel) for superficial and deeper partial-thickness burns in pediatric patients.
  • To assess the dressing's impact on hospital stay, pain management, re-epithelialization time, infection rates, and patient/parent satisfaction.

Main Methods:

  • A pilot study involving pediatric patients with partial-thickness burns (average 5% total body surface area).
  • Copolymer dressing applied as a primary wound dressing after debridement.
  • Retrospective evaluation of clinical outcomes and staff experience.

Main Results:

  • Average hospital stay was 1.4 days with minimal narcotic use post-application.
  • Average re-epithelialization time was 9.5 days with no burn wound infections.
  • High patient/parent satisfaction (average 3.66/4) and ease of application reported by staff.

Conclusions:

  • Copolymer dressing facilitates early discharge, pain management, and high satisfaction in pediatric burn patients.
  • The synthetic dressing is versatile, suitable for deeper burns, donor sites, and contoured areas.
  • It simplifies wound care without needing additional antimicrobial coverage.
Abstract

Related Concept Videos

Burn Injuries01:22

Burn Injuries

Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
5.0K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
817
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.4K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
484